1 INDICATIONS AND USAGE
Limitations of Use: NATPARA was not studied in patients with hypoparathyroidism caused by calcium-sensing receptor mutations.
14 CLINICAL STUDIES
- Study in Patients with Established Hypoparathyroidism
Patients with hypoparathyroidism due to calcium-sensing receptor mutations were excluded from the trial.
Medication Guide
- What is NATPARA?
NATPARA was not studied in people with hypoparathyroidism caused by calcium-sensing receptor mutations.